<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9-pharmaceuticals-13-00455">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Davis</surname>
    <given-names>E.L.</given-names>
   </name>
   <name>
    <surname>Oh</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Butow</surname>
    <given-names>P.N.</given-names>
   </name>
   <name>
    <surname>Mullan</surname>
    <given-names>B.A.</given-names>
   </name>
   <name>
    <surname>Clarke</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: A Systematic Review</article-title>
  <source>Oncologist</source>
  <year>2012</year>
  <volume>17</volume>
  <fpage>1475</fpage>
  <lpage>1481</lpage>
  <pub-id pub-id-type="doi">10.1634/theoncologist.2012-0223</pub-id>
  <pub-id pub-id-type="pmid">22933591</pub-id>
 </element-citation>
</ref>
